{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:17:27Z","timestamp":1787980647052,"version":"build-2784847793"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Nosocomial pneumonia (NP) remains associated with excess morbidity and mortality. The effect of NP on measures such as re-admission at 30 days remains unclear. Moreover, differing types of NP may have varying impacts on re-admissions.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We conducted a multicenter retrospective cohort study within the Premier Research database, a source containing administrative, pharmacy, and microbiology data. We compared NP patients readmitted with pneumonia (RaP) as the principal diagnosis to those readmitted for other reasons (RaO) with respect to the type of NP (ventilator-associated bacterial pneumonia [VABP], ventilated hospital-acquired bacterial pneumonia [vHABP], and non-ventilated HABP [nvHABP]), and characteristics and outcomes of the index hospitalization.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Among 17,819 patients with NP, 14,123 (79.3%) survived to discharge, of whom 2,151 (15.2%) required an acute readmission within 30 days of index discharge. Of these, 106 (4.9%) were RaP, and the remainder were RaO. At index hospitalization, RaP patients were older (mean age [SD] 67.4 (13.9] vs. 63.0 [15.2] years), more likely medical (44.3% vs. 36.7%), and less chronically ill (median [IQR] Charlson scores (3 [2\u20135] vs. 4 [2\u20135]) than persons with RaO. Bacteremia (10.4% vs. 17.5%), need for vasopressors (15.1% vs. 20.0%), dialysis (9.4% vs. 16.5%), and\/or sepsis (9.4% vs. 16.5%) or septic shock 14.2% vs. 17.1%) occurred less frequently in the RaP group. With respect to NP type, nvHABP was most common in RaP (47.2%) and VABP in RaO (38.1%).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>One in seven survivors of a hospitalization complicated by NP requires an acute rehospitalization within 30 days. However, few of these readmissions had a principal diagnosis of pneumonia, irrespective of NP type. Of the 5% of NP subjects with RaP, the plurality initially suffered from nvHABP.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0276192","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T18:30:24Z","timestamp":1670610624000},"page":"e0276192","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Descriptive epidemiology of hospitalized patients with\u00a0bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014\u20132019"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7266-9761","authenticated-orcid":true,"given":"Marya D.","family":"Zilberberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Puzniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah W. D.","family":"Zilberberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Shorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"issue":"13","key":"pone.0276192.ref001","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","author":"SS Magill","year":"2014","journal-title":"N Engl J Med"},{"key":"pone.0276192.ref002","unstructured":"Hospital Value Based Purchasing. Available at https:\/\/www.cms.gov\/Medicare\/Quality-Initiatives-Patient-Assessment-Instruments\/HospitalQualityInits\/Hospital-Value-Based-Purchasing-; accessed November 23, 2021."},{"key":"pone.0276192.ref003","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/jamainternmed.2016.2427","article-title":"Associations between ventilator bundle components and outcomes","volume":"176","author":"M Klompas","year":"2016","journal-title":"JAMA Intern Med"},{"key":"pone.0276192.ref004","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1378\/chest.122.1.262","article-title":"Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia","volume":"122","author":"M Iregui","year":"2002","journal-title":"Chest"},{"key":"pone.0276192.ref005","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/AAC.00851-07","article-title":"Health care-associated pneumonia and community-acquired pneumonia: a single-center experience","volume":"51","author":"ST Micek","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"pone.0276192.ref006","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF01712153","article-title":"ICU-acquired Pneumonia Study Group. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit","volume":"22","author":"F Alvarez-Lerma","year":"1996","journal-title":"Intensive Care Med"},{"issue":"5","key":"pone.0276192.ref007","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1378\/chest.08-0842","article-title":"Antimicrobial therapy escalation and hospital mortality among patients with HCAP: a single center experience","volume":"134","author":"MD Zilberberg","year":"2008","journal-title":"Chest"},{"issue":"2","key":"pone.0276192.ref008","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"MH Kollef","year":"1999","journal-title":"Chest"},{"key":"pone.0276192.ref009","unstructured":"US Department of Health and Human Services Office for Human Research Protections. Human Subject Regulations Decision Charts. Available at https:\/\/www.hhs.gov\/ohrp\/regulations-and-policy\/decision-charts\/index.html; accessed November 23, 2021."},{"key":"pone.0276192.ref010","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.chest.2018.12.024","article-title":"A novel algorithm to analyze epidemiology and outcomes of carbapenem resistance among patients with hospital-acquired and ventilator-associated pneumonia: A retrospective cohort study","volume":"155","author":"MD Zilberberg","year":"2019","journal-title":"Chest"},{"key":"pone.0276192.ref011","article-title":"Descriptive epidemiology and outcomes of non-ventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the US, 2014\u20132019","author":"MD Zilberberg","year":"2021","journal-title":"Crit Care Med"},{"key":"pone.0276192.ref012","article-title":"Microbiology, empiric therapy, and its impact on the outcomes of non-ventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the US, 2014\u20132019","author":"MD Zilberberg","journal-title":"Infect Control Hosp Epidemiol"},{"key":"pone.0276192.ref013","doi-asserted-by":"crossref","first-page":"e00346","DOI":"10.1128\/AAC.00346-20","article-title":"Antimicrobial Susceptibility and Cross-Resistance Patterns among Common Complicated Urinary Tract Infections in U.S. Hospitals, 2013 to 2018","volume":"64","author":"MD Zilberberg","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"pone.0276192.ref014","doi-asserted-by":"crossref","first-page":"ofz504","DOI":"10.1093\/ofid\/ofz504","article-title":"Carbapenem treatment and outcomes among patients with culture-positive complicated intra-abdominal infections in US hospitals: A retrospective cohort study","volume":"6","author":"MD Zilberberg","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"pone.0276192.ref015","doi-asserted-by":"crossref","first-page":"e87382","DOI":"10.1371\/journal.pone.0087382","article-title":"Using highly detailed administrative data to predict pneumonia mortality","volume":"9","author":"MB Rothberg","year":"2014","journal-title":"PLoS One"},{"issue":"Suppl 3","key":"pone.0276192.ref016","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1086\/677829","article-title":"Outcomes of patients with healthcare-associated pneumonia: worse disease or sicker patients?","volume":"35","author":"MB Rothberg","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"pone.0276192.ref017","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jhm.2199","article-title":"The impact of hospital-onset Clostridium difficile infection on outcomes of hospitalized patients with sepsis","volume":"9","author":"T Lagu","year":"2014","journal-title":"J Hosp Med"},{"key":"pone.0276192.ref018","author":"American College of Surgeons","year":"2011","journal-title":"National Trauma Data Bank User Manual"},{"issue":"8","key":"pone.0276192.ref019","doi-asserted-by":"crossref","first-page":"e0135834","DOI":"10.1371\/journal.pone.0135834","article-title":"Validity of diagnostic codes for acute stroke in administrative databases: A systematic review","volume":"10","author":"N McCormick","year":"2015","journal-title":"PLoS One"},{"key":"pone.0276192.ref020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","article-title":"Clinical and economic burden of community-acquired pneumonia among adults in Europe","volume":"67","author":"T Welte","year":"2012","journal-title":"Thorax"},{"key":"pone.0276192.ref021","volume-title":"Healthcare Cost and Utilization Project (HCUP) statistical briefs","author":"A Elixhauser","year":"2013"},{"key":"pone.0276192.ref022","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/1077558716647652","article-title":"Discharge planning and hospital readmissions","volume":"74","author":"RM Henke","year":"2017","journal-title":"Med Care Res Rev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0276192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T18:30:35Z","timestamp":1670610635000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0276192"}},"subtitle":[],"editor":[{"given":"Steven Eric","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":22,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0276192","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]}}}